ENHABIT INC (EHAB) Stock Fundamental Analysis
NYSE:EHAB - US29332G1022 - Common Stock
7.88 USD
-0.04 (-0.51%)
7.88 USD
0 (0%)
EHAB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. EHAB has a medium profitability rating, but doesn't score so well on its financial health evaluation. EHAB has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
EHAB had positive earnings in the past year.
In the past year EHAB had a positive cash flow from operations.
In multiple years EHAB reported negative net income over the last 5 years.
Each year in the past 5 years EHAB had a positive operating cash flow.
1.2 Ratios
The Return On Assets of EHAB (-10.87%) is worse than 77.23% of its industry peers.
The Return On Equity of EHAB (-24.11%) is worse than 66.34% of its industry peers.
EHAB has a Return On Invested Capital of 3.98%. This is comparable to the rest of the industry: EHAB outperforms 49.51% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EHAB is significantly below the industry average of 9.14%.
The last Return On Invested Capital (3.98%) for EHAB is above the 3 year average (3.74%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.87% | ||
| ROE | -24.11% | ||
| ROIC | 3.98% |
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
1.3 Margins
Looking at the Operating Margin, with a value of 5.31%, EHAB is in the better half of the industry, outperforming 62.38% of the companies in the same industry.
In the last couple of years the Operating Margin of EHAB has declined.
Looking at the Gross Margin, with a value of 48.88%, EHAB is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
In the last couple of years the Gross Margin of EHAB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.31% | ||
| PM (TTM) | N/A | ||
| GM | 48.88% |
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
2. Health
2.1 Basic Checks
EHAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
EHAB has more shares outstanding than it did 1 year ago.
EHAB has a worse debt/assets ratio than last year.
2.2 Solvency
EHAB has an Altman-Z score of 1.56. This is a bad value and indicates that EHAB is not financially healthy and even has some risk of bankruptcy.
EHAB has a Altman-Z score of 1.56. This is in the lower half of the industry: EHAB underperforms 60.40% of its industry peers.
EHAB has a debt to FCF ratio of 9.72. This is a negative value and a sign of low solvency as EHAB would need 9.72 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.72, EHAB is in line with its industry, outperforming 52.48% of the companies in the same industry.
EHAB has a Debt/Equity ratio of 0.83. This is a neutral value indicating EHAB is somewhat dependend on debt financing.
EHAB has a Debt to Equity ratio of 0.83. This is comparable to the rest of the industry: EHAB outperforms 42.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 9.72 | ||
| Altman-Z | 1.56 |
ROIC/WACC0.44
WACC9.12%
2.3 Liquidity
EHAB has a Current Ratio of 1.57. This is a normal value and indicates that EHAB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.57, EHAB is in line with its industry, outperforming 52.48% of the companies in the same industry.
EHAB has a Quick Ratio of 1.57. This is a normal value and indicates that EHAB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.57, EHAB is in line with its industry, outperforming 55.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.57 | ||
| Quick Ratio | 1.57 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 30.43% over the past year.
The Revenue has decreased by -0.39% in the past year.
The Revenue has been decreasing by -1.07% on average over the past years.
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%2.11%
3.2 Future
EHAB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.40% yearly.
The Revenue is expected to grow by 5.57% on average over the next years.
EPS Next Y139.94%
EPS Next 2Y62.45%
EPS Next 3Y43.04%
EPS Next 5Y0.4%
Revenue Next Year2.84%
Revenue Next 2Y3.58%
Revenue Next 3Y3.8%
Revenue Next 5Y5.57%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 26.27, the valuation of EHAB can be described as expensive.
62.38% of the companies in the same industry are more expensive than EHAB, based on the Price/Earnings ratio.
EHAB's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.08.
Based on the Price/Forward Earnings ratio of 14.22, the valuation of EHAB can be described as correct.
Based on the Price/Forward Earnings ratio, EHAB is valued a bit cheaper than the industry average as 79.21% of the companies are valued more expensively.
EHAB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.72, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.27 | ||
| Fwd PE | 14.22 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EHAB indicates a somewhat cheap valuation: EHAB is cheaper than 69.31% of the companies listed in the same industry.
89.11% of the companies in the same industry are more expensive than EHAB, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.1 | ||
| EV/EBITDA | 10.14 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EHAB's earnings are expected to grow with 43.04% in the coming years.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y62.45%
EPS Next 3Y43.04%
5. Dividend
5.1 Amount
No dividends for EHAB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.88
-0.04 (-0.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners99.65%
Inst Owner ChangeN/A
Ins Owners3.11%
Ins Owner Change26.23%
Market Cap399.44M
Analysts76.36
Price Target9.56 (21.32%)
Short Float %3.11%
Short Ratio2.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.27%
Min EPS beat(2)23.34%
Max EPS beat(2)53.19%
EPS beat(4)2
Avg EPS beat(4)6.47%
Min EPS beat(4)-28.32%
Max EPS beat(4)53.19%
EPS beat(8)5
Avg EPS beat(8)23.89%
EPS beat(12)6
Avg EPS beat(12)6.38%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-4.23%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-3.12%
Min Revenue beat(4)-4.98%
Max Revenue beat(4)-0.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.4%
Revenue beat(12)0
Avg Revenue beat(12)-3.61%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.54%
PT rev (3m)4.17%
EPS NQ rev (1m)4.35%
EPS NQ rev (3m)120.59%
EPS NY rev (1m)12.79%
EPS NY rev (3m)12.79%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-0.79%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.27 | ||
| Fwd PE | 14.22 | ||
| P/S | 0.38 | ||
| P/FCF | 8.1 | ||
| P/OCF | 7.57 | ||
| P/B | 0.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.14 |
EPS(TTM)0.3
EY3.81%
EPS(NY)0.55
Fwd EY7.03%
FCF(TTM)0.97
FCFY12.34%
OCF(TTM)1.04
OCFY13.22%
SpS20.47
BVpS10.9
TBVpS-7.83
PEG (NY)0.19
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.87% | ||
| ROE | -24.11% | ||
| ROCE | 5.03% | ||
| ROIC | 3.98% | ||
| ROICexc | 4.12% | ||
| ROICexgc | 40.3% | ||
| OM | 5.31% | ||
| PM (TTM) | N/A | ||
| GM | 48.88% | ||
| FCFM | 4.75% |
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
ROICexc(3y)3.81%
ROICexc(5y)4.84%
ROICexgc(3y)39.56%
ROICexgc(5y)58.49%
ROCE(3y)4.73%
ROCE(5y)6.02%
ROICexcg growth 3Y-27.94%
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.68%
ROICexc growth 5YN/A
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
F-Score5
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 9.72 | ||
| Debt/EBITDA | 5.49 | ||
| Cap/Depr | 12.46% | ||
| Cap/Sales | 0.34% | ||
| Interest Coverage | 1.46 | ||
| Cash Conversion | 63.46% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.57 | ||
| Quick Ratio | 1.57 | ||
| Altman-Z | 1.56 |
F-Score5
WACC9.12%
ROIC/WACC0.44
Cap/Depr(3y)51.64%
Cap/Depr(5y)35.82%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
EPS Next Y139.94%
EPS Next 2Y62.45%
EPS Next 3Y43.04%
EPS Next 5Y0.4%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%2.11%
Revenue Next Year2.84%
Revenue Next 2Y3.58%
Revenue Next 3Y3.8%
Revenue Next 5Y5.57%
EBIT growth 1Y49.73%
EBIT growth 3Y-31.17%
EBIT growth 5Y-5.31%
EBIT Next Year77.79%
EBIT Next 3Y25.2%
EBIT Next 5YN/A
FCF growth 1Y1073.81%
FCF growth 3Y-26.15%
FCF growth 5Y0%
OCF growth 1Y19.19%
OCF growth 3Y-25.39%
OCF growth 5Y-2.96%